Onslow Road Drive-in Pharmacy

Open
Call
Website

Advertisement

159 Onslow Rd
Shenton Park, Western Australia 6008
+61 8 9381 8029
https://greenleafpharmacies.com.au

Onslow Road Drive-in Pharmacy, located in Shenton Park, Western Australia, is part of a network of independently owned Greenleaf Pharmacies dedicated to providing high-quality health services and professional advice. The pharmacy offers a wide range of services including vaccinations, medication management, and personalized health consultations, ensuring that community members receive comprehensive care.

The pharmacy also features a rewards club that allows customers to earn points on purchases, which can be redeemed at any Greenleaf location across Perth. With a focus on community wellness, Onslow Road Drive-in Pharmacy aims to improve the health and well-being of its clientele through expert service and a variety of health-related products.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Greenleaf Pharmacy Shenton Park

Greenleaf Pharmacy Shenton Park is part of a network of independently owned pharmacies located throughout Perth, Western Australia. They offer a wide range of health services including vaccinations, medication management, compounding medicine, and pain management, ensuring a high standard of service across all locations. The pharmacy is dedicated to improving community health and wellness, providing expert advice and professional support. With a rewards club allowing customers to earn points on their purchases, Greenleaf Pharmacy Shenton Park provides a convenient and engaging shopping experience for its patrons. Generated from the website

Shenton Pharmacy

Respirion Pharmaceuticals

Respirion Pharmaceuticals, located in Nedlands, Western Australia, is dedicated to developing innovative treatments for lung infections associated with cystic fibrosis, a condition impacting 1 in 3,500 births globally. Their groundbreaking inhaled treatment combines a widely used antibiotic with a biofilm-disrupting agent, showing promise in improving lung function and bacterial clearance in initial studies. The company is currently conducting a Phase 2 clinical trial for RSP1502, aimed at addressing chronic lung infections in cystic fibrosis patients. This initiative reflects Respirion's commitment to advancing therapeutic options for those affected by this challenging condition. Generated from the website
Australia›Western Australia›Onslow Road Drive-in Pharmacy

Advertisement